↓ Skip to main content

American Association for Cancer Research

ONC212 is a Novel Mitocan Acting Synergistically with Glycolysis Inhibition in Pancreatic CancerONC212 Dampens Mitochondria in Pancreatic Cancer

Overview of attention for article published in Molecular Cancer Therapeutics, June 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (72nd percentile)
  • Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

twitter
13 X users

Readers on

mendeley
22 Mendeley